CELLULAR BIOMEDICINE GROUP news, videos and press releases - Page 2
For more news please use our advanced search feature.
CELLULAR BIOMEDICINE GROUP - More news...
CELLULAR BIOMEDICINE GROUP - More news...
- Cellular Biomedicine Group Announces Receipt of a Preliminary Non-Binding "Going Private" Proposal
- Cellular Biomedicine Group Reports Third Quarter of 2019 Financial Results and Business Highlights
- Cellular Biomedicine Group to Report Third Quarter 2019 Results on November 6, 2019
- Cellular Biomedicine Group Announces New Facility to Expand Research and Development and to Support Clinical Development
- Cellular Biomedicine Group to Present at the 2019 Cantor Global Healthcare Conference
- Cellular Biomedicine Group's ReJoin® Therapy Receives Stem Cell Drug Application Acceptance For Phase II Clinical Trials by China NMPA
- Cellular Biomedicine Group Hosts Meeting with Investigators to Launch AlloJoin® Knee Osteoarthritis Phase II Clinical Trial
- Cellular Biomedicine Group to Present at 5th Annual CAR-TCR Summit in Boston
- Cellular Biomedicine Group to Present at Baird's 2019 Global Healthcare Conference
- Cellular Biomedicine Group Reports Second Quarter and First Half of 2019 Financial Results and Business Highlights
- Cellular Biomedicine Group to Report Second Quarter 2019 Results on August 6, 2019
- Cellular Biomedicine Group Executives to Present at CAR-TCR Summit Asia
- Cellular Biomedicine Group Announces First Patient Dosing in Phase I Clinical Trial of Anti-CD20 CAR-T for Lymphoma in China
- Cellular Biomedicine Group to Present at International Society for Cell and Gene Therapy Annual Meeting
- Cellular Biomedicine Group to Present at B. Riley FBR Annual Investor Conference
- Cellular Biomedicine Group Reports First Quarter 2019 Results and Highlights Operational Progress
- Cellular Biomedicine Group Announces Results of 2019 Annual Meeting of Stockholders
- Cellular Biomedicine Group to Report First Quarter 2019 Results and Host Conference Call on May 1, 2019
- Cellular Biomedicine Group Upgraded to NASDAQ Global Select Market
- Cellular Biomedicine Group to Participate in Asia Pharma R&D Leaders Summit 2019
- Cellular Biomedicine Group to Present at Annual BioCentury Future Leaders in the Biotech Industry Conference
- Cellular Biomedicine Group (CBMG) Announces Annual Meeting of Stockholders
- Cellular Biomedicine Group Announces Pricing of Public Offering of Common Stock
- Cellular Biomedicine Group Announces Proposed Follow-on Offering of Common Stock
- Cellular Biomedicine Group to Present at 8th Annual SVB Leerink Global Healthcare Conference
- Cellular Biomedicine Group Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Operational Progress
- Cellular Biomedicine Group's AlloJoin® Therapy for Knee Osteoarthritis (KOA) Becomes the First Stem Cell Drug Application Approved in China for Phase II Clinical Trials
- Cellular Biomedicine Group Initiates Patient Recruitment for Clinical Trial in B Cell Maturation Antigen (Anti-BCMA) Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Targeting Multiple Myeloma (MM)
- Cellular Biomedicine Grp
- Cellular Biomedicine Group (CBMG) Approved to Commence Phase I Trial (CALL-1) for C-CAR011 in Adult Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia (ALL) in China